How Pfizer Inc. Puts Money Ahead Of Their Customers

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

“Research in pharmaceuticals doesn’t scale well,” says Scott Gottlieb, resident fellow at the American Enterprise Institute. So why is Pfizer [PFE] offering $119 billion to buy AstraZeneca [AZN], the Swedish-British drug giant? The deal, if consummated, would result in the world’s largest pharmaceutical company.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC